谷歌浏览器插件
订阅小程序
在清言上使用

Abstract GS03-13: Inavolisib or Placebo in Combination with Palbociclib and Fulvestrant in Patients with PIK3CA-mutated, Hormone Receptor-Positive, HER2-negative Locally Advanced or Metastatic Breast Cancer: Phase III INAVO120 Primary Analysis

Cancer Research(2024)

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要